missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ SMIP 004

Description
SMIP 004 is a SKP2 (S-phase kinase-associated protein 2) inhibitor. Upregulates p27 and activates the unfolded protein response (UPR) in LNCaP prostate cancer cells overexpressing SKP2. Also induces oxidative stress. Induces proteasomal degradation of cyclin D1 and acts as CDK2 inhibitor. Arrests cell cycle in G1 phase and induces apoptosis in prostate cancer cells, but not normal cells in vitro. Inhibits growth of breast and prostate cancer xenografts in mice. Also induces autophagy and reduces replication of MERS-CoV in VeroB4 cells.
Specifications
Specifications
| Chemical Name or Material | N-(4-Butyl-2-methylphenyl)acetamide |
| CAS | 143360-00-3 |
| Quantity | 50 mg |
| Target | Ubiquitin Ligase (E3) Inhibitors |
| Molecular Formula | C13H19NO |
| Purity | 0.98 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?